{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:18:01Z","timestamp":1793395081747,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clgc.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T09:51:30Z","timestamp":1683453090000},"page":"e386-e393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1134-0188","authenticated-orcid":false,"given":"Yasuyuki","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyotaro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9675-2589","authenticated-orcid":false,"given":"Shigeki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-186X","authenticated-orcid":false,"given":"Yumiko","family":"Yasuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotsugu","family":"Ichimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clgc.2023.05.004_bib0001","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clgc.2023.05.004_bib0002","first-page":"62","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupret","year":"2021","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2023.05.004_bib0003","first-page":"1224","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.clgc.2023.05.004_bib0004","first-page":"2178","article-title":"Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter: relation to tumor proliferation and survival","volume":"79","author":"Rey","year":"1997","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2023.05.004_bib0005","first-page":"e831","article-title":"Ki-67 as a prognostic marker in upper urinary tract urothelial carcinoma: a systematic review and meta-analysis","volume":"16","author":"Ahn","year":"2018","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2023.05.004_bib0006","first-page":"221","article-title":"The role of p53 on survival of upper urinary tract urothelial carcinoma: a systematic review and meta-analysis","volume":"11","author":"Ku","year":"2013","journal-title":"Clin Genitourin Cancer"},{"issue":"16","key":"10.1016\/j.clgc.2023.05.004_bib0007","first-page":"R921","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"issue":"5","key":"10.1016\/j.clgc.2023.05.004_bib0008","first-page":"472","article-title":"Macrophages: the road less traveled, changing anticancer therapy","volume":"24","author":"Guerriero","year":"2018","journal-title":"Trends Mol Med"},{"issue":"8","key":"10.1016\/j.clgc.2023.05.004_bib0009","first-page":"1458","article-title":"Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma: a systematic review and meta-analysis","volume":"33","author":"L\u00f3pez-Janeiro","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clgc.2023.05.004_bib0010","first-page":"222","article-title":"Attributes of alternatively activated (M2) macrophages","volume":"224","author":"Shrivastava","year":"2019","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.clgc.2023.05.004_bib0011","first-page":"462","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.clgc.2023.05.004_bib0012","first-page":"277","article-title":"Macrophage regulation of tumor responses to anticancer therapies","volume":"23","author":"De Palma","year":"2013","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.clgc.2023.05.004_bib0013","first-page":"2721","article-title":"CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder","volume":"37","author":"Yang","year":"2019","journal-title":"World J Urol"},{"issue":"7","key":"10.1016\/j.clgc.2023.05.004_bib0014","first-page":"1203","article-title":"Tumor-associated macrophage infiltration and prognosis in colorectal cancer: systematic review and meta-analysis","volume":"35","author":"Li","year":"2020","journal-title":"Int J Colorectal Dis"},{"issue":"15","key":"10.1016\/j.clgc.2023.05.004_bib0015","first-page":"5497","article-title":"Targeting of CD163(+) macrophages in inflammatory and malignant diseases","volume":"21","author":"Skytthe","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clgc.2023.05.004_bib0016","series-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","year":"2016"},{"issue":"24","key":"10.1016\/j.clgc.2023.05.004_bib0017","first-page":"20204","article-title":"High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.clgc.2023.05.004_bib0018","first-page":"791","article-title":"Infiltration of CD3(+) and CD68(+) cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors","volume":"32","author":"Sj\u00f6dahl","year":"2014","journal-title":"Urol Oncol"},{"issue":"21","key":"10.1016\/j.clgc.2023.05.004_bib0019","first-page":"7252","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2023.05.004_bib0020","article-title":"High counts of CD68+ and CD163+ macrophages in mantle cell lymphoma are associated with inferior prognosis","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.clgc.2023.05.004_bib0021","first-page":"1175","article-title":"Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy","volume":"45","author":"Wu","year":"2015","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2023.05.004_bib0022","first-page":"14","article-title":"Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter","volume":"86","author":"Kamai","year":"2000","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.clgc.2023.05.004_bib0023","first-page":"764","article-title":"Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma","volume":"48","author":"Fromont","year":"2005","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.clgc.2023.05.004_bib0024","first-page":"6519","article-title":"High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder","volume":"15","author":"Xu","year":"2018","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.clgc.2023.05.004_bib0025","first-page":"709","article-title":"Microlocalization and clinical significance of stabilin-1(+) macrophages in treatment-naive patients with urothelial carcinoma of the bladder","volume":"38","author":"Wang","year":"2020","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.clgc.2023.05.004_bib0026","first-page":"1122","article-title":"A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma","volume":"67","author":"Seisen","year":"2015","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2023.05.004_bib0027","first-page":"2756","article-title":"Macrophage polarity in cancer: a review","volume":"120","author":"Najafi","year":"2019","journal-title":"J Cell Biochem"},{"issue":"7","key":"10.1016\/j.clgc.2023.05.004_bib0028","first-page":"946","article-title":"Prognostic versus predictive value of biomarkers in oncology","volume":"44","author":"Oldenhuis","year":"2008","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.clgc.2023.05.004_bib0029","first-page":"1083","article-title":"Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram","volume":"106","author":"Yates","year":"2012","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.clgc.2023.05.004_bib0030","first-page":"1130","article-title":"External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma","volume":"109","author":"Ku","year":"2013","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2023.05.004_bib0031","article-title":"A model for the prediction of survival in patients with upper tract urothelial carcinoma after surgery","volume":"17","author":"Zhang","year":"2019","journal-title":"Dose Response"},{"issue":"9","key":"10.1016\/j.clgc.2023.05.004_bib0032","first-page":"1526","article-title":"External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy","volume":"26","author":"Shariat","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2023.05.004_bib0033","first-page":"224","article-title":"Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the European Association of Urology Guidelines Panel on non-muscle-invasive bladder cancer","volume":"5","author":"Dominguez-Escrig","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"3","key":"10.1016\/j.clgc.2023.05.004_bib0034","first-page":"291","article-title":"Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis","volume":"91","author":"Fang","year":"2013","journal-title":"Urol Int"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323001064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323001064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:36:51Z","timestamp":1761565011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767323001064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1558767323001064"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2023.05.004","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}